Sep 2026· Neurobiology of Disease· Vol 230, pp.
107632
· 0 citations· 66 references
Medicine
TL;DR
It is demonstrated that deptor deficiency drives cholesterol dysregulation, causing structural and functional abnormalities in the nervous system, highlighting cholesterol metabolism as a potential therapeutic target for neurological disorders associated with mTOR pathway dysfunction.
Abstract
The mechanistic target of rapamycin (mTOR) signaling pathway is a highly conserved regulator of cellular growth and survival. DEPTOR serves as an endogenous inhibitor of this pathway by directly binding to both mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). While DEPTOR is extensively implicated in oncology and peripheral metabolism, its role in the nervous system remains poorly understood. In this study, we utilized CRISPR/Cas9 technology to disrupt deptor in the zebrafish model to investigate its neurodevelopmental functions. We found that deptor-/- larvae exhibit motor deficits alongside structural axonal abnormalities, characterized by misaligned and broadened axonal tracts. These phenotypes were accompanied by the transcriptional dysregulation of key cholesterol-regulatory genes and progressive, aberrant accumulation of cholesterol from 5 to 10 days post-fertilization. Pharmacological elevation of cholesterol levels recapitulated these axonal and behavioral defects in wild-type larvae, whereas clearance of excess cholesterol successfully rescued the mutant phenotype. Together, our findings demonstrate that deptor deficiency drives cholesterol dysregulation, causing structural and functional abnormalities in the nervous system. This study uncovers a novel link between DEPTOR, lipid homeostasis, and neurodevelopment, highlighting cholesterol metabolism as a potential therapeutic target for neurological disorders associated with mTOR pathway dysfunction.
It is demonstrated that tmlhe deficiency disrupts carnitine biosynthesis, impairing energy and glycerophospholipid metabolism, which is critical for early neurogenesis, which may lead to impaired neural development and a synaptic E/I imbalance, ultimately causing ASD-like phenotypes.
Ji-Tong Li, Xiao-Tong Zhao, Jie-Ru Wei et al.· Progress in Neuro-psychophar...· 0 citations
ABSTRACT The zinc finger transcription factor PLAG1 has been implicated in multiple diverse cellular processes, yet its role in the onset of vertebrate neurodevelopment and behaviour remains largely unexplored. Notably, dysregulation of PLAG1 has been associated with Silver–Russell syndrome (SRS) in humans, a growth di...
Jemma G. Gasperoni, Jarrad N. Fuller, April L. Lewis et al.· International Journal of Dev...· 0 citations
Abstract Katanins are microtubule-severing ATPases. Dysfunction of katanin subunits has been implicated in impaired neurogenesis, morphogenesis, and neuronal migration. Although heterozygous variants in KATNAL2 (katanin-like 2), a known autism-spectrum disorder (ASD) risk gene, have been reported in patients with ASD o...
Ece Sonmezler, Semra Hız Kurul, Ozlem Erez et al.· Human Molecular Genetics· 0 citations
Summary Axonal and synaptic degeneration are key hallmarks of neurodegenerative diseases, but the molecular mechanisms remain incompletely understood. Here, we performed an unbiased forward genetic mosaic screen in Drosophila to identify genes required for maintenance of adult motor axons and neuromuscular junctions (N...
Marije Been, Erwan Lambert, Ana Serna et al.· iScience· 0 citations
ABSTRACT mTORC1 activity is increased in muscle with aging and is implicated as a potential driver of age‐related declines in muscle health. While pharmacological inhibition of mTORC1 improves lifespan and healthspan, it remains unclear whether chronic activation of mTORC1 is sufficient to accelerate aging in skeletal...
Erik D. Marchant, Hanna Kalenta, Jacquelyn T. May et al.· Aging Cell· 0 citations
Loss-of-function mutations in the GATOR1 complex (NPRL2, NPRL3, and DEPDC5) are among the most common genetic causes of epilepsy. These mutations impair amino acid-dependent regulation of mTORC1 and cause hyperactive signaling, neuronal hyperexcitability, astrocytic metabolic remodeling, seizures, and early mortality....
Imane Hadj-Aissa, Maéline Muller, Antoine Desmeules et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.